GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (STU:IL3) » Definitions » EV-to-FCF

Integra Lifesciences Holdings (STU:IL3) EV-to-FCF : 202.14 (As of Apr. 05, 2025)


View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Integra Lifesciences Holdings's Enterprise Value is €2,918 Mil. Integra Lifesciences Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was €14 Mil. Therefore, Integra Lifesciences Holdings's EV-to-FCF for today is 202.14.

The historical rank and industry rank for Integra Lifesciences Holdings's EV-to-FCF or its related term are showing as below:

STU:IL3' s EV-to-FCF Range Over the Past 10 Years
Min: 22.4   Med: 51.53   Max: 246.91
Current: 217.23

During the past 13 years, the highest EV-to-FCF of Integra Lifesciences Holdings was 246.91. The lowest was 22.40. And the median was 51.53.

STU:IL3's EV-to-FCF is ranked worse than
95.04% of 383 companies
in the Medical Devices & Instruments industry
Industry Median: 27.06 vs STU:IL3: 217.23

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-05), Integra Lifesciences Holdings's stock price is €17.70. Integra Lifesciences Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.073. Therefore, Integra Lifesciences Holdings's PE Ratio (TTM) for today is At Loss.


Integra Lifesciences Holdings EV-to-FCF Historical Data

The historical data trend for Integra Lifesciences Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings EV-to-FCF Chart

Integra Lifesciences Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.59 25.77 26.91 65.36 230.57

Integra Lifesciences Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.36 68.46 67.47 81.85 230.57

Competitive Comparison of Integra Lifesciences Holdings's EV-to-FCF

For the Medical Devices subindustry, Integra Lifesciences Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integra Lifesciences Holdings's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Integra Lifesciences Holdings's EV-to-FCF falls into.


;
;

Integra Lifesciences Holdings EV-to-FCF Calculation

Integra Lifesciences Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2917.840/14.435
=202.14

Integra Lifesciences Holdings's current Enterprise Value is €2,918 Mil.
Integra Lifesciences Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integra Lifesciences Holdings  (STU:IL3) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Integra Lifesciences Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=17.70/-0.073
=At Loss

Integra Lifesciences Holdings's share price for today is €17.70.
Integra Lifesciences Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.073.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Integra Lifesciences Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Integra Lifesciences Holdings Business Description

Traded in Other Exchanges
Address
1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings Headlines

No Headlines